The CSOP A50 ETF (2822) and the iShares A50 ETF (2823) both purport to track the FTSE China A50 Index.
I would expect there to be similar performance from the two ETFs with the lower expense ratio of 2822 (1.15% v 1.39%) resulting in a small positive divergence over time.
However, the five year total return shows the more expensive 2823 generating a slightly higher return (52.79% v 54.85%). Possibly this is explained by 2823 starting the 5 year period at a slightly larger discount to NAV and that discount narrowing over time? Both currently trade at almost the same small premium to NAV (1.290% v 2.272%).
There have been differences in distributions by two ETFs in almost every year which is strange given they track the same index and having only slight variations in their top ten holdings. Total distributions over the last 5 years are RMB1.34 for 2822 and RMB 1.28 for 2823. What I don't understand is why 2823 only distributed RMB0.11 in 2018 compared to 2822's RMB0.27.
Both ETF's are sufficiently large that liquidity is a non-issue for small investors like me.
Against that background, I have two questions:
1. Given the lower expense ratio, is there any reason not to prefer 2822 over 2823 for my exposure to Chinese equities?
2. Are there alternatives for gaining broad exposure to Chinese equity markets (without remitting funds into the mainland directly)?
Comparison table is here: ETF - ETF Comparison